Skip to main navigation Skip to search Skip to main content

Plasmodium falciparum: New molecular targets with potential for antimalarial drug development

  • Donald L. Gardiner
  • , Tina S. Skinner-Adams
  • , Christopher L. Brown
  • , Katherine T. Andrews
  • , Colin M. Stack
  • , James S. McCarthy
  • , John P. Dalton
  • , Katharine R. Trenholme
  • QIMR Berghofer Medical Research Institute
  • Griffith University
  • University of Western Sydney
  • University of Queensland
  • McGill University, Macdonald Campus

Research output: Contribution to a Journal (Peer & Non Peer)Review articlepeer-review

35 Citations (Scopus)

Abstract

Malaria remains one of the world's most devastating infectious diseases. Drug resistance to all classes of antimalarial agents has now been observed, highlighting the need for new agents that act against novel parasite targets. The complete sequencing of the Plasmodium falciparum genome has allowed the identification of new molecular targets within the parasite that may be amenable to chemotherapeutic intervention. In this review, we investigate four possible targets for the future development of new classes of antimalarial agents. These targets include histone deacetylase, the aspartic proteases or plasmepsins, aminopeptidases and the purine salvage enzyme hypoxanthine-xanthine-guanine phosphoribosyltransferase.

Original languageEnglish
Pages (from-to)1087-1098
Number of pages12
JournalExpert Review of Anti-Infective Therapy
Volume7
Issue number9
DOIs
Publication statusPublished - Nov 2009
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Aminopeptidase
  • Aspartic protease
  • Histone deacetylase
  • Hypoxanthine-xanthine- guanine phosphoribosyltransferase
  • Malaria
  • Molecular target
  • Plasmepsin
  • Plasmodium falciparum

Fingerprint

Dive into the research topics of 'Plasmodium falciparum: New molecular targets with potential for antimalarial drug development'. Together they form a unique fingerprint.

Cite this